DPP4 and type 2 diabetes mellitus: The GRADE (Glycemia Reduction Approaches in Diabetes) study is ongoing and includes approximately 5000 individuals with type 2 diabetes receiving metformin hydrochloride and randomized to additional medications (sulfonylurea, dipeptidyl peptidase 4 inhibitor, glucagonlike peptide 1 receptor agonist, and insulin).